Excess Mortality since COVID-19: What Data Do We Need and What Questions Should We Ask to Understand its Causes in Portugal?

Vasco Ricoca Peixoto; André Vieira; Pedro Aguiar; Alexandre Abrantes

doi:10.20344/amp.19080

Excess Mortality since COVID-19: What Data Do We Need and What Questions Should We Ask to Understand its Causes in Portugal?

Authors

Vasco Ricoca Peixoto NOVA National School of Public Health. Public Health Research Centre. Universidade Nova de Lisboa. Lisbon. Comprehensive Health Research Centre. Universidade NOVA de Lisboa. Lisbon. https://orcid.org/0000-0002-7529-8206
André Vieira NOVA National School of Public Health. Public Health Research Centre. Universidade Nova de Lisboa. Lisbon. Comprehensive Health Research Centre. Universidade NOVA de Lisboa. Lisbon. https://orcid.org/0000-0002-7462-5535
Pedro Aguiar NOVA National School of Public Health. Public Health Research Centre. Universidade Nova de Lisboa. Lisbon. Comprehensive Health Research Centre. Universidade NOVA de Lisboa. Lisbon. https://orcid.org/0000-0002-0074-7732
Alexandre Abrantes NOVA National School of Public Health. Public Health Research Centre. Universidade Nova de Lisboa. Lisbon. Comprehensive Health Research Centre. Universidade NOVA de Lisboa. Lisbon. https://orcid.org/0000-0002-1047-3464

DOI:

https://doi.org/10.20344/amp.19080

Keywords:

COVID-19, Death Certificates, Health Surveys, Healthcare Services, Mortality

Abstract

N/a.

Downloads

Download data is not yet available.

References

Eurostat. Excess mortality - statistics - Statistics Explained. [cited 2022 Sep 08]. Available from: https://ec.europa.eu/eurostat/statisticsexplained/index.php?title=Excess_mortality_-_statistics.

Shkolnikov VM, Klimkin I, McKee M, Jdanov DA, Alustiza-Galarza A, Németh L, et al. What should be the baseline when calculating excess mortality? New approaches suggest that we have underestimated the impact of the COVID-19 pandemic and previous winter peaks. SSM Popul Health. 2022;18101118.

COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21. Lancet. 2022;399:1513-36.

Sousa Pinto C, Anderson RN, Martins H, Marques C, Maia C, Borralho MC. Mortality information system in Portugal: transition to e-death certification. Eurohealth. 2016;22:1-53.

Pita Ferreira P, Godinho Simões D, Pinto de Carvalho C, Duarte F, Fernandes E, Casaca P, et al. A real-time classification of causes of

death using artificial intelligence: sensitivity analysis. JMIR Preprints. 11/07/2022:40965.

Eurostat. Persons at risk of poverty or social exclusion by age and sex. [cited 2022 Sep 19]. Available from: https://ec.europa.eu/eurostat/databrowser/view/ilc_peps01n/default/table?lang=en.

Uusküla A, Jürgenson T, Pisarev H, Kolde R, Meister T, Tisler A, et al. Long-term mortality following SARS-CoV-2 infection: a national cohort study from Estonia. Lancet Reg Health Eur. 2022;18:100394.

Downloads

Published

2022-09-27

How to Cite

Ricoca Peixoto V, Vieira A, Aguiar P, Abrantes A. Excess Mortality since COVID-19: What Data Do We Need and What Questions Should We Ask to Understand its Causes in Portugal?. Acta Med Port [Internet]. 2022 Sep. 27 [cited 2024 Dec. 23];35(11):783-5. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/19080

Download Citation

Issue

Vol. 35 No. 11 (2022): November

Section

Editorial

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.